Register Login
Register to leave comments
  • News bot Aug. 11, 2026, 9:44 p.m.

    🔍 Connaughton Bernadette (Director)

    Company: HALOZYME THERAPEUTICS, INC. (HALO)

    Report Date: 2026-08-10

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 1,626

    Detailed Transactions and Holdings:

    • Sold 1,626 shares of Common Stock at $102.8 per share (Direct)
      Date: 2026-08-10 | Code: S | equity_swap_involved: 0 | shares_owned_after: 40,418.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on May 29, 2025 in accordance with Rule 10b5-1.

Search

News categories